Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010;55(1):54-63.
doi: 10.4103/0019-5154.60355.

Epidemiology, clinical manifestations, and diagnosis of Chikungunya fever: lessons learned from the re-emerging epidemic

Affiliations

Epidemiology, clinical manifestations, and diagnosis of Chikungunya fever: lessons learned from the re-emerging epidemic

Alladi Mohan et al. Indian J Dermatol. 2010.

Abstract

Chikungunya fever, caused by "Chikungunya virus," is an arbovirus disease transmitted by the bite of infected mosquitoes belonging to the genus Aedes. Chikungunya fever epidemics have been reported from several countries around the world. The disease that was silent for nearly 32 years re-emerged in the October 2005 outbreak in India that is still ongoing. The incubation period ranges from 3 to 12 days. The onset is usually abrupt and the acute stage is characterized by sudden onset with high-grade fever, severe arthralgias, myalgias, and skin rash. Swollen tender joints and crippling arthritis are usually evident. In the chronic stage, relapses that include sensation of fever, asthenia, exacerbation of arthralgias, inflammatory polyarthritis, and stiffness may be evident. Neurological, ocular, and mucocutaneous manifestations have also been described. Chronic arthritis may develop in about 15% of the patients. Viral culture is the gold standard for the diagnosis of Chikungunya fever. Reverse transcription polymerase chain reaction and real-time loop-mediated isothermal amplification have also been found to be useful. Serodiagnostic methods for the detection of immunoglobulin M and immunoglobulin G antibodies against Chikungunya virus are more frequently used. Chikungunya is a self-limiting disease; however, severe manifestations such as meningoencephalitis, fulminant hepatitis, and bleeding manifestations may sometimes be life-threatening. Treatment is symptomatic and supportive. Prevention by educating the community and public health officials, vector control measures appear to be the best approach at controlling Chikungunya fever as no commercially available vaccine is available for public use in India for this condition presently.

Keywords: Chikungunya; diagnosis; epidemiology; treatment.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: Nil.

Figures

Figure 1
Figure 1
Crippling arthritis involving small joints of the hands, wrist, elbow, shoulder, knee, and ankle joints in a patient with Chikungunya fever. As the name “Chikungunya” (“that which bends up”) suggests, stooped posture of the patient is evident
Figure 2
Figure 2
Symmetrical inflammatory polyarthritis of the small joints of the hands and tenosynovitis of the wrist joints in a patient with chronic stage of Chikungunya fever

References

    1. Mohan A. Chikungunya fever: clinical manifestations & management. Indian J Med Res. 2006;124:471–4. - PubMed
    1. Mohan A, Sharma SK. Chikungunya fever. In: Singal RK, editor. Medicine update. Mumbai: Association of Physicians of India; 2007. pp. 634–8.
    1. Mohan A. Chikungunya fever strikes in Andhra Pradesh. Natl Med J India. 2006;19:240.
    1. Simon F, Savini H, Parola P. Chikungunya: a paradigm of emergence and globalization of vector-borne diseases. Med Clin North Am. 2008;92:1323–43. ix. - PubMed
    1. Sudeep AB, Parashar D. Chikungunya: an overview. J Biosci. 2008;33:443–9. - PubMed